GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - OSL:GENT - NO0010748866 - Common Stock
56.6 NOK
+2.4 (+4.43%)
GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. GENT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
GENT had a positive operating cash flow in the past year.
In the past 5 years GENT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of GENT (18.25%) is better than 94.92% of its industry peers.
Looking at the Return On Equity, with a value of 21.37%, GENT belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
GENT has a Return On Invested Capital of 7.59%. This is in the better half of the industry: GENT outperforms 69.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 25.83%, GENT belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.
GENT has a better Operating Margin (12.10%) than 61.02% of its industry peers.
With a Gross Margin value of 54.19%, GENT perfoms like the industry average, outperforming 50.85% of the companies in the same industry.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GENT is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
GENT has about the same amout of shares outstanding than it did 5 years ago.
GENT has a better debt/assets ratio than last year.
2.2 Solvency
GENT has an Altman-Z score of 15.82. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
GENT's Altman-Z score of 15.82 is amongst the best of the industry. GENT outperforms 100.00% of its industry peers.
GENT has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.33, GENT belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
GENT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
GENT has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. GENT outperforms 93.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 15.82 |
ROIC/WACC0.9
WACC8.46%
2.3 Liquidity
A Current Ratio of 5.47 indicates that GENT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.47, GENT belongs to the best of the industry, outperforming 96.61% of the companies in the same industry.
GENT has a Quick Ratio of 3.78. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.78, GENT belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2103.43%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 11.68% in the last year.
The Revenue has been growing by 25.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.72% on average per year.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GENT is valuated rather expensively with a Price/Earnings ratio of 21.04.
Based on the Price/Earnings ratio, GENT is valued a bit cheaper than 79.66% of the companies in the same industry.
GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.27.
The Price/Forward Earnings ratio is 20.86, which indicates a rather expensive current valuation of GENT.
66.10% of the companies in the same industry are more expensive than GENT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of GENT to the average of the S&P500 Index (22.77), we can say GENT is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.04 | ||
| Fwd PE | 20.86 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
The rest of the industry has a similar Price/Free Cash Flow ratio as GENT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 92.21 | ||
| EV/EBITDA | 26.35 |
4.3 Compensation for Growth
GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.71%, which is pretty low.
GENT's Dividend Yield is comparable with the industry average which is at 2.30.
Compared to an average S&P500 Dividend Yield of 2.38, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (9/16/2025, 4:17:34 PM)
56.6
+2.4 (+4.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners26.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap872.77M
Analysts85.71
Price Target68.34 (20.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.55%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.04 | ||
| Fwd PE | 20.86 | ||
| P/S | 5.34 | ||
| P/FCF | 92.21 | ||
| P/OCF | 43.87 | ||
| P/B | 4.42 | ||
| P/tB | 5.26 | ||
| EV/EBITDA | 26.35 |
EPS(TTM)2.69
EY4.75%
EPS(NY)2.71
Fwd EY4.79%
FCF(TTM)0.61
FCFY1.08%
OCF(TTM)1.29
OCFY2.28%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 15.82 |
F-Score5
WACC8.46%
ROIC/WACC0.9
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A